Trials / Sponsors / Orano Med LLC
Orano Med LLC
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tu Cervical Cancer, Breast Cancer, Colon Cancer | Phase 1 | 2022-12-22 |
| Active Not Recruiting | Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients Neuroendocrine Tumors | Phase 2 | 2021-12-21 |
| Terminated | Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET Neuroendocrine Tumor | Phase 1 | 2018-02-05 |
| Completed | Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy Breast Neoplasms, Peritoneal Neoplasms, Ovarian Neoplasms | Phase 1 | 2011-07-01 |